Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Visa Inc (V) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Visa Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Visa Inc trades at $394.69 (market cap $734.85B). The key difference: Visa Inc is far larger — about 23.8× GE HealthCare Technologies Inc. Common Stock's market cap, and Visa Inc pays the higher dividend (0.68%). Which is the better fit depends on your goals.
| GEHC | V | |
|---|---|---|
Market Cap | $30.93B | $734.85B |
Volume | 5,033,451 | 7,725,378 |
Sector | Health | Financials |
52-Week High | $88.16 | $396.06 |
52-Week Low | $59.48 | $295.52 |
Enterprise Value | $39.39B | $745.43B |
Dividend Yield | 0.23% | 0.68% |
Typical Hold Time | — | 115 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Visa (V) trades at $396.06, up 1.74% today, near its 52-week high. The stock shows strong technical momentum with bullish moving averages and key resistance at $399. Fundamentally, Visa reported robust earnings beats in recent quarters, with Q2 2026 results due April 28. Revenue grew to $40B in 2025, with a net income margin of 50.78%, though the P/E ratio of 33.71 is elevated. Recent news highlights Visa's push into AI-driven commerce and stablecoin partnerships.
Outlook remains positive with 85% analyst buy ratings and a $423.29 consensus target, implying 7% upside. Risks include competitive fintech threats and regulatory scrutiny. Strong cash flow and institutional accumulation support long-term growth, but high valuation requires sustained execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →
